2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab

Authors :: Anna V Tinker
Renaud Sabatier
Adriano Gravina
Lucy Gilbert
Jubilee Brown
Vanessa Samouëlian
Clare J Reade
Cara Mathews
Susan Ellard
Susana Banerjee
Maria Pillar Barretina-Ginesta
Rowan Miller
Charles Leath
Bhavana Pothuri
Tao Duan
Xinwei Han
Eleftherios Zografos
Jennifer Veneris
Ana Oaknin
Source :: Translational research/biomarkers.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools